<DOC>
	<DOCNO>NCT02126306</DOCNO>
	<brief_summary>Oral administration betaglucosylceramide show effective reduce inflammation animal model find safe human .</brief_summary>
	<brief_title>Beta Glucosylceramide Treatment NASH</brief_title>
	<detailed_description>Patients NASH receive treatment versus placebo 40 week follow liver biopsy .</detailed_description>
	<criteria>Biopsy proven NASH Other therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2006</verification_date>
</DOC>